Skip to main content

Is Sunosi (solriamfetol) a controlled substance?

Medically reviewed by Last updated on Aug 31, 2023.

Official answer


Yes. Sunosi (solriamfetol) is a Schedule IV Controlled Substance in the United States.

Sunosi (solriamfetol) is a selective dopamine and norepinephrine reuptake inhibitor (DNRI) for the treatment of excessive sleepiness in adult patients with narcolepsy or obstructive sleep apnea (OSA). It was approved by the FDA in March 2019.

Sunosi is a federally controlled substance (CIV) because it contains solriamfetol, which has the potential for abuse.

Sunosi should always be stored in a safe place to protect it from theft. Any unused or expired Sunosi should be disposed of via a medication take-back program, or mixed with an undesirable substance and thrown away in the household trash.

Related medical questions

Drug information

Related support groups